http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021156718-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dd554226db6acd26c2c6b6051e3b54d6
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6869
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H10-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-742
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-689
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-747
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-741
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16B10-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6883
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16B50-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16B20-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16B20-00
filingDate 2021-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_33d7bfc740039771dc182d5b65403bdb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ccf27f0691f99036bb4931a93bc40da
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5c904e744c96404306dc25db0022a42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23aa5004516f6743a23b1d73103b641f
publicationDate 2021-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2021156718-A3
titleOfInvention Method and composition for microbiome based amelioration of skin associated autoimmune inflammatory diseases
abstract Skin-associated autoimmune diseases are common these days. A method and composition for microbiome based amelioration of skin associated autoimmune inflammatory diseases has been provided. The composition is made of at least one or more of microbiome-associated compounds such as proteins, metabolites, antibiotics, probiotics, etc. The method provides a composition for an affected individual through application of these compositions aimed at improving the bioavailability of lipoic acid. It acts through modulation of the lipoic acid metabolic pathway to do the same. The suggested microbes and compounds can either be used as an effective probiotic supplement in increasing the microbial population involved in lipoic acid biosynthesis (only), or increasing the number of competitors of the microbes involved in escalation of lipoic acid salvage system, or through direct antibiotic or physical action against the latter.
priorityDate 2020-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015259728-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016321416-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017228514-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010074963-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018303934-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399223
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6112

Total number of triples: 38.